pyrroles has been researched along with Sezary Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonefeld, CM; Fredholm, S; Geisler, C; Gniadecki, R; Iversen, L; Kilian, M; Koralov, SB; Krejsgaard, T; Lindahl, LM; Litvinov, IV; Mongan, NP; Nastasi, C; Odum, N; Petersen, DL; Sasseville, D; Wasik, MA; Willerslev-Olsen, A; Woetmann, A | 1 |
Bayle, P; Bazex, J; Chouini-Lalanne, N; D'Incan, M; Drugeon, C; Gadroy, A; Journe, F; Marguery, MC | 1 |
Ranki, A | 1 |
3 other study(ies) available for pyrroles and Sezary Syndrome
Article | Year |
---|---|
Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.
Topics: Cell Line, Tumor; Coculture Techniques; Enterotoxins; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin Receptor Common gamma Subunit; Interleukin-17; Lymphocyte Activation; Male; Neoplasm Proteins; Piperidines; Pyrimidines; Pyrroles; Sezary Syndrome; STAT3 Transcription Factor; T-Lymphocytes | 2016 |
UV-B phototoxic effects induced by atorvastatin.
Topics: Anticholesteremic Agents; Atorvastatin; Dermatitis, Phototoxic; Diagnosis, Differential; Female; Heptanoic Acids; Humans; Middle Aged; Pyrroles; Sezary Syndrome; Skin Neoplasms; Skin Tests; Ultraviolet Rays | 2006 |
Bexarotene combination therapy for patients with Sézary syndrome.
Topics: Antineoplastic Agents; Atorvastatin; Bexarotene; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes; Thyroxine | 2008 |